William P. McGuinn, MD, FACC, is a cardiologist at University Hospitals Harrington Heart & Vascular Institute.
Dr. McGuinn earned his medical degree from the Medical College of Ohio in Toledo. His postdoctoral training included an internal medicine residency at Akron City Hospital followed by invasive cardiology and cardiac electrophysiology fellowships at the Cleveland Clinic. After private practice in Newport Beach, California, he returned to Northeast Ohio and joined North Ohio Heart, Inc., where he has dedicated his medical career to serving patients over the past 20 years.
Dr. McGuinn is board certified in cardiovascular disease with special interest in the field of cardiac electrophysiology and associated medical conditions, including common and complex heart rhythm disorders. He also has vast experience in diagnosing and treating other heart conditions such as coronary artery disease, congestive heart failure and heart valve disease.
Dr. McGuinn has authored publications and presented at medical conferences on topics related to cardiac pacing, vasovagal syncope, implantable defibrillators, electrophysiology studies and pulmonary thromboembolism. He is a member of national professional organizations including the Heart Rhythm Society, American Heart Association and American Medical Association. He is also recognized as a fellow of the American College of Cardiology. On a local level, Dr. McGuinn is a member of the Erie County Medical Society.
- Cardiac Electrophysiology
Certifications & Memberships
- Cardiovascular Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Electrophysiology
Electrophysiology - Cleveland Clinic (1990 - 1991)
Fellowship | Cardiovascular Disease
Cardiovascular Disease - Cleveland Clinic (1987 - 1990)
Residency | Internal Medicine
Internal Medicine - Akron City Hospital (Summa Health System) (1984 - 1987)
Medical College Of Ohio (1980 - 1984)
Wright State University (1980)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, William Mcguinn did not disclose any Outside Relationships with Industry.